CRISPR Therapeutics AG (CRSP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

BAARERSTRASSE 14 ZUG, SWITZERLAND CH-6300

CRISPR Therapeutics AG is a bio-technology company. The Company researches, develops, and manufactures biological transformative gene-based medicines and other related products. CRISPR Therapeutics operates in Switzerland.

Data based on most recent fiscal year report
Market Cap3.208 Billion Shares Outstanding55.2 Million Avg Volume984.991 Thousand
1-Yr BETA vs S&P TR2.107 Current Ratio16.81 Quick Ratio16.81
View SEC Filings from CRSP instead.

View recent insider trading info

Funds Holding CRSP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRSP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

8 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GREENE JOHN EVP & CHIEF FINANCIAL OFFICER

27,502 2020-01-27 2

BEHBAHANI ALI

  • Director
19,500,000 2020-01-24 1

LUNDBERG SVEN ANTE PRESIDENT, CEO & PFO

  • Officer
  • Director
0 2020-01-03 0

COLES N ANTHONY

  • Director
643 2020-01-02 0

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
12,455,252 2020-01-01 0

HIGH KATHERINE A SEE REMARKS

  • Officer
  • Director
0 2019-12-17 2

KULKARNI SAMARTH CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
172,320 2019-12-16 9

KASINGER JAMES R. GENERAL COUNSEL AND SECRETARY

  • Officer
0 2019-12-03 3

HO TONY W EXECUTIVE VP, HEAD OF R&D

  • Officer
0 2019-12-03 3

TOMSICEK MICHAEL JOHN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-03 2

KLEIN LAWRENCE OTTO CHIEF BUSINESS OFFICER

  • Officer
0 2019-12-03 4

BOLZON BRADLEY J PHD

  • Director
4,205,615 2019-11-19 3

CAGNONI PABLO J

  • Director
0 2019-11-19 4

NOVAK RODGER PRESIDENT

  • Officer
  • Director
0 2019-11-19 5

GEORGE SIMEON

  • Director
2,982,855 2019-10-18 1

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
0 2019-09-30 0

WOIWODE THOMAS

  • Director
0 2019-07-31 0

EMSTER KURT VON

  • Director
0 2019-01-29 0

CELGENE CORP /DE/

6,824,685 2019-01-18 0

VERTEX PHARMACEUTICALS (EUROPE) LTD

VERTEX PHARMACEUTICALS INC / MA

  • 10% Owner
5,380,940 2018-12-26 0

BECKER MARC

  • Director
0 2018-06-25 0

VERSANT VENTURE CAPITAL V, L.P.

VERSANT VENTURES V, LLC

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
1,729,151 2018-04-24 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
4,004,248 2018-04-20 0

DYLAN-HYDE TYLER CHIEF LEGAL OFFICER

  • Officer
25,204 2018-01-16 0

BAYER AKTIENGESELLSCHAFT

BAYER GLOBAL INVESTMENTS B.V.

  • 10% Owner
5,708,747 2018-01-05 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

VERSANT VENTURES IV, LLC

VERSANT VENTURES V, LLC

VERSANT VENTURES V (CANADA), L.P.

  • 10% Owner
4,606,242 2017-09-05 0

SUBRAMANIAN KALA SEE REMARKS

  • Officer
0 2017-06-15 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT AFFILIATES FUND V, L.P.

VERSANT OPHTHALMIC AFFILIATES I, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
6,909,347 2016-10-24 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURE CAPITAL V, L.P.

VERSANT VENTURE CAPITAL V (CANADA), LP

  • 10% Owner
6,758,169 2016-10-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-16 M 8,000 d 195,058 172,320.00 direct

KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-16 M 8,000 $1.81 a 172,320 172,320.00 direct

KLEIN LAWRENCE OTTO - Officer CHIEF BUSINESS OFFICER

2019-12-03 A 40,000 a 40,000 0.00 direct

KASINGER JAMES R. - Officer GENERAL COUNSEL AND SECRETARY

2019-12-03 A 20,000 a 20,000 0.00 direct

TOMSICEK MICHAEL JOHN - Officer CHIEF FINANCIAL OFFICER

2019-12-03 A 20,000 a 20,000 0.00 direct

HO TONY W - Officer EXECUTIVE VP, HEAD OF R&D

2019-12-03 A 40,000 a 40,000 0.00 direct

KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-03 A 120,000 a 120,000 0.00 direct

KULKARNI SAMARTH - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-01 F 741 $71.65 d 164,320 164,320.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments